US SB909 | 2021-2022 | 117th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 6-1)
Status: Introduced on March 23 2021 - 25% progression, died in chamber
Action: 2021-03-23 - Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 23 2021 - 25% progression, died in chamber
Action: 2021-03-23 - Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
Title
Prescription Drug Price Relief Act of 2021
Sponsors
| Sen. Bernard Sanders [I-VT] | Sen. Richard Blumenthal [D-CT] | Sen. Cory Booker [D-NJ] | Sen. Kirsten Gillibrand [D-NY] |
| Sen. Amy Klobuchar [D-MN] | Sen. Alex Padilla [D-CA] | Sen. Elizabeth Warren [D-MA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-03-23 | Senate | Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held. |
| 2021-03-23 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB2148 (Same As) 2021-10-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/senate-bill/909/all-info |
| Text | https://www.congress.gov/117/bills/s909/BILLS-117s909is.pdf |
